Episode

Young-Onset ALS: Diagnosis and Research

Podcast
Amplifying the Patient Journey
Published
Nov 8, 2024
Duration seconds
1210
Processing state
not_requested
Canonical source
https://traffic.megaphone.fm/BMCL7810266134.mp3?updated=1731071531
Audio
https://traffic.megaphone.fm/BMCL7810266134.mp3?updated=1731071531
JSON
/v1/public/podcasts/amplifying-the-patient-journey-6685265/episodes/young-onset-als-diagnosis-and-research
Markdown
/podcast/amplifying-the-patient-journey-6685265/young-onset-als-diagnosis-and-research.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/amplifying-the-patient-journey-6685265/episodes/young-onset-als-diagnosis-and-research/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/amplifying-the-patient-journey-6685265/young-onset-als-diagnosis-and-research.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode, Gwen Petersen discusses her long journey to receiving an ALS diagnosis at age 32, her contributions to a Cytokinetics book project, and the importance of clinical trial participation. We are also joined by Merit Cudkowicz, MD, MSc, Head of the Department of Neurology, Chief of Neurology, and Director of the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital in Boston, MA who discusses the PLATFORM-ALS trial and the drugs currently in the clinical research and development pipeline.